Ocugen (OCGN) Shareholder's Equity (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147.71% |
| Dec 31, 2025 | -444.35% |
| Sep 30, 2025 | 15.76% |
| Jun 30, 2025 | -80.82% |
| Mar 31, 2025 | -46.29% |
| Dec 31, 2024 | -27.07% |
| Sep 30, 2024 | 140.03% |
| Jun 30, 2024 | -44.06% |
| Mar 31, 2024 | -25.40% |
| Dec 31, 2023 | -18.55% |
| Sep 30, 2023 | -15.94% |
| Jun 30, 2023 | -8.72% |
| Mar 31, 2023 | -12.27% |
| Dec 31, 2022 | -13.66% |
| Sep 30, 2022 | -19.53% |
| Jun 30, 2022 | -15.16% |
| Mar 31, 2022 | 37.63% |
| Dec 31, 2021 | -14.85% |
| Sep 30, 2021 | -7.99% |
| Jun 30, 2021 | 150.40% |
| Mar 31, 2021 | 115.73% |
| Dec 31, 2020 | 49.43% |
| Sep 30, 2020 | -1.38% |
| Jun 30, 2020 | 100.40% |
| Mar 31, 2020 | -33.78% |
| Dec 31, 2019 | 184.16% |
| Sep 30, 2019 | -114.44% |
| Jun 30, 2019 | 67.19% |
| Mar 31, 2019 | -46.41% |
| Dec 31, 2018 | -79.47% |
| Sep 30, 2018 | -31.75% |
| Jun 30, 2018 | -1,456.18% |
| Mar 31, 2018 | -107.79% |
| Dec 31, 2017 | 192.15% |
| Sep 30, 2017 | -697.15% |
| Jun 30, 2017 | -88.44% |
| Mar 31, 2017 | -48.61% |
| Dec 31, 2016 | 236.15% |
| Sep 30, 2016 | -68.69% |
| Jun 30, 2016 | -37.41% |
| Mar 31, 2016 | -26.97% |
| Dec 31, 2015 | -22.05% |
| Sep 30, 2015 | -17.53% |
| Jun 30, 2015 | -14.37% |
| Mar 31, 2015 | -5.50% |